CHICAGO – Elderly dementia patients prescribed antipsychotic drugs are at three times the risk of a serious health problem or dying within a month of treatment, compared to those not given the drugs, Canadian researchers said Monday.
The medications have been used by doctors to treat aggression in people who are not psychotic or schizophrenic, but there are risks for elderly dementia patients prescribed the drugs, according to Dr. Paula Rochon of the Institute for Clinical Evaluative Sciences in Toronto, and colleagues.
“Of residents newly admitted to a nursing home, 17 per cent are started on antipsychotic drugs within 100 days of their admission,” often for short periods to control delirium, delusions or aggressive behaviour, Rochon wrote.
“Antipsychotic drugs should be prescribed with caution even for short-term therapy,” she concluded.
Three years ago, the U.S. Food and Drug Administration required warnings on antipsychotic drugs notifying patients and doctors of the risks of heart problems or infections in elderly dementia patients.
Previous research has suggested the drugs cause dry mouth and difficulty swallowing, which can lead to pneumonia.
Side-effects such as dizziness can increase the risk of falls.
The seven-year study of more than 40,000 people age 65 or older — half in nursing homes — found 5.2 per cent of the nursing homes residents died within a month of being given one of the newer class of so-called atypical antipsychotic drugs…
Atypical antipsychotic drugs, which the study said had been available for about a decade, include risperidone, marketed by Johnson & Johnson as Risperdal; olanzapine, made by Eli Lilly and Co under the brand name Zyprexa; and quetiapine, sold by AstraZeneca Plc under the brand name Seroquel…